Suzuki-Miyaura reactions are one of the most commonly used reactions in organic chemistry in which carbon-carbon bond is formed in the presence of a metal catalyst. The main advantages of this type of reactions are mild conditions, insensitivity of boronic acid to water and air as well as good transfer of the laboratory method to the industrial level. Optimization of parameters are a key part of reaction planning, which ensures the success and high yields of the selected synthesis.
As a part of this master´s thesis, the Suzuki-Miyaura reaction on 2,4-dichloropyrimidine was optimized for further synthesis of 4-aryl-6-trifluoromethylpyrimidine class of potential Toll-like receptor 8 (TLR8) antagonists. At the beginning of the method optimization process, we selected the most optimal solvent, which was later used for a series of reactions using different catalysts. The catalyst that showed the highest reaction yield was further used for determination of the lowest amount which still led to high yields. Afterwards, the reaction temperature was optimized. For the final optimized method we used 1,4-dioxane as a solvent, 3 mol % of tetrakis(triphenylphosphine) palladium(0) catalyst relative to the input of 2,4-dichloropyrimidine and a reaction temperature of 90 ºC.
The optimized reaction method was then transferred to the first step of the synthesis of potential TLR8 antagonists, where it was proved as an efficient method for the preparation of 2-chloro-4-phenly-6-(trifluoromethyl)pyrimidine intermediate (1), while in the synthesis of 2-chloro-4-(furan-3-yl)-6-(trifluoromethyl)pyrimidine (2) the method was showed to be less efficient since the yield was lower as expected. 2-thiophenylmethylamine was added to intermediates 1 and 2 to prepare the final products 4-phenyl-N-(thiophen-2-ylmethyl)-6-(trifluoromethyl)pyrimidin-2-amine (3) and 4-(furan-3-yl)-N-(thiophen-2-ylmethyl)-6-(trifluoromethyl)pyrimidin-2-amine (4), which were subjected to biochemical evaluation of TLR8 antagonist activity. The preliminary results showed that compound 3 possess some TLR8 antagonist activity, while compound 4 still needs to be evaluated.
|